BNGO logo

Bionano Genomics (BNGO) Cash From Investing

Annual CFI

$24.16 M
-$58.61 M-70.81%

December 31, 2023

Summary

Performance

1-Year Change

-70.81%

3-Year Change

+1086.04%

5-Year Change

+7383.09%

15-Year Change

+2473.55%

BNGO Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

82.95%
BNGO annual cash flow from investing activities is higher than 82.95% of companies in Healthcare sector

High & Low

All-time High

$82.77 M
BNGO annual cash flow from investing activities is currently -70.81% below its historical high of $82.77 million

3-Year Low

-$278.06 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2023
BNGO previous annual earnings announcement was published on Dec 31, 2023

Next Annual Earnings Report Date

Mar 5, 2025
BNGO next annual earnings announcement is scheduled for Mar 5, 2025

OtherBNGOcash flowmetrics:

Annual CFF

$113.81 M
BNGO annual cash flow from financing activities is $113.81 million

Annual CFO

-$125.18 M
BNGO annual cash flow from operations is -$125.18 million

Annual FCF

-$126.87 M
BNGO annual free cash flow is -$126.87 million

Annual CAPEX

$1.69 M
BNGO annual capital expenditures is $1.69 million

Quarterly CFI

-$5.38 M
-$34.01 M-118.77%

September 1, 2024

Summary

Performance

3-Month Change

-118.77%

1-Year Change

+90.29%

3-Year Change

-116.82%

5-Year Change

-100%

BNGO Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

26.9%
BNGO quarterly cash flow from investing activities is higher than 26.9% of companies in Healthcare sector

High & Low

All-time High

$47.59 M
BNGO quarterly cash flow from investing activities is currently -111.30% below its historical high of $47.59 million

3-Year Low

-$92.51 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
BNGO previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 5, 2025
BNGO next earnings announcement is scheduled for Mar 5, 2025

OtherBNGOcash flowmetrics:

Quarterly CFF

$6.02 M
BNGO quarterly cash flow from financing activities is $6.02 million

Quarterly CFO

-$13.31 M
BNGO quarterly cash flow from operations is -$13.31 million

Quarterly FCF

-$13.31 M
BNGO quarterly free cash flow is -$13.31 million

Quarterly CAPEX

$0.00
BNGO quarterly capital expenditures is $0.00

TTM CFI

$15.47 M
-$38.80 M-71.50%

September 1, 2024

Summary

Performance

3-Month Change

-71.5%

1-Year Change

-35.97%

3-Year Change

+106.29%

5-Year Change

+49839.55%

BNGO TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

81.98%
BNGO TTM cash flow from investing activities is higher than 81.98% of companies in Healthcare sector

High & Low

All-time High

$91.14 M
BNGO TTM cash flow from investing activities is currently -83.03% below its historical high of $91.14 million

3-Year Low

-$278.06 M

Earnings dates

Last Quarterly Earnings Report Date

Sep 1, 2024
BNGO previous earnings announcement was published on Sep 1, 2024

Next Quarterly Earnings Report Date

Mar 5, 2025
BNGO next earnings announcement is scheduled for Mar 5, 2025

OtherBNGOcash flowmetrics:

TTM CFF

$50.91 M
BNGO TTM cash flow from financing activities is $50.91 million

TTM CFO

-$92.20 M
BNGO TTM cash flow from operations is -$92.20 million

TTM FCF

-$93.05 M
BNGO TTM free cash flow is -$93.05 million

TTM CAPEX

$848.00 K
BNGO TTM capital expenditures is $848.00 thousand

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

BNGO Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-70.8%+90.3%-36.0%
3 y3 years+1086.0%-116.8%+106.3%
5 y5 years+7383.1%-100.0%+10000.0%

BNGO Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-70.8%+108.7%-111.3%+94.2%-83.0%+105.6%
5 y5-year-70.8%+108.7%-111.3%+97.1%-83.0%+105.6%
alltimeall time-70.8%+108.7%-111.3%+97.1%-83.0%+105.6%

Bionano Genomics Cash From Investing History

DateAnnualQuarterlyTTM
Sep 2024
-
-$5.38 M(-118.8%)
$15.47 M(-71.5%)
Jun 2024
-
$28.63 M(-39.8%)
$54.27 M(-1.7%)
Mar 2024
-
$47.59 M(-185.9%)
$55.22 M(+128.6%)
Dec 2023
$24.16 M(-70.8%)
-$55.37 M(-265.7%)
$24.16 M(-73.5%)
Sep 2023
-
$33.43 M(+13.0%)
$91.14 M(+38.8%)
Jun 2023
-
$29.58 M(+78.9%)
$65.67 M(-2.5%)
Mar 2023
-
$16.53 M(+42.4%)
$67.33 M(-18.6%)
Dec 2022
$82.77 M(-129.8%)
$11.61 M(+46.0%)
$82.77 M(-487.6%)
Sep 2022
-
$7.95 M(-74.5%)
-$21.35 M(-90.1%)
Jun 2022
-
$31.24 M(-2.3%)
-$214.91 M(-12.7%)
Mar 2022
-
$31.96 M(-134.6%)
-$246.07 M(-11.5%)
Dec 2021
-$278.06 M(>+9900.0%)
-$92.51 M(-50.2%)
-$278.06 M(+49.9%)
Sep 2021
-
-$185.60 M(<-9900.0%)
-$185.55 M(+7631.3%)
Jun 2021
-
$74.00 K(-408.3%)
-$2.40 M(-3.0%)
Mar 2021
-
-$24.00 K(<-9900.0%)
-$2.47 M(+1.0%)
DateAnnualQuarterlyTTM
Dec 2020
-$2.45 M(+3909.8%)
$0.00(-100.0%)
-$2.45 M(-0.9%)
Sep 2020
-
-$2.45 M(<-9900.0%)
-$2.47 M(+7852.1%)
Jun 2020
-
$0.00(0.0%)
-$31.10 K(-49.1%)
Mar 2020
-
$0.00(-100.0%)
-$61.10 K(0.0%)
Dec 2019
-$61.10 K(-81.6%)
-$23.10 K(+188.8%)
-$61.10 K(+22.7%)
Sep 2019
-
-$8000.00(-73.3%)
-$49.80 K(-71.1%)
Jun 2019
-
-$30.00 K(+154.2%)
-$172.30 K(-48.1%)
Dec 2018
-$331.70 K(-67.4%)
-$11.80 K(-91.0%)
-$331.70 K(-44.9%)
Sep 2018
-
-$130.50 K(-26.5%)
-$601.70 K(-19.3%)
Jun 2018
-
-$177.60 K(+1405.1%)
-$745.30 K(-22.2%)
Mar 2018
-
-$11.80 K(-95.8%)
-$958.10 K(-5.9%)
Dec 2017
-$1.02 M(-24.6%)
-$281.80 K(+2.8%)
-$1.02 M(+38.3%)
Sep 2017
-
-$274.10 K(-29.8%)
-$736.00 K(+59.3%)
Jun 2017
-
-$390.40 K(+446.0%)
-$461.90 K(+546.0%)
Mar 2017
-
-$71.50 K
-$71.50 K
Dec 2016
-$1.35 M
-
-

FAQ

  • What is Bionano Genomics annual cash flow from investing activities?
  • What is the all time high annual CFI for Bionano Genomics?
  • What is Bionano Genomics annual CFI year-on-year change?
  • What is Bionano Genomics quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Bionano Genomics?
  • What is Bionano Genomics quarterly CFI year-on-year change?
  • What is Bionano Genomics TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Bionano Genomics?
  • What is Bionano Genomics TTM CFI year-on-year change?

What is Bionano Genomics annual cash flow from investing activities?

The current annual CFI of BNGO is $24.16 M

What is the all time high annual CFI for Bionano Genomics?

Bionano Genomics all-time high annual cash flow from investing activities is $82.77 M

What is Bionano Genomics annual CFI year-on-year change?

Over the past year, BNGO annual cash flow from investing activities has changed by -$58.61 M (-70.81%)

What is Bionano Genomics quarterly cash flow from investing activities?

The current quarterly CFI of BNGO is -$5.38 M

What is the all time high quarterly CFI for Bionano Genomics?

Bionano Genomics all-time high quarterly cash flow from investing activities is $47.59 M

What is Bionano Genomics quarterly CFI year-on-year change?

Over the past year, BNGO quarterly cash flow from investing activities has changed by +$50.00 M (+90.29%)

What is Bionano Genomics TTM cash flow from investing activities?

The current TTM CFI of BNGO is $15.47 M

What is the all time high TTM CFI for Bionano Genomics?

Bionano Genomics all-time high TTM cash flow from investing activities is $91.14 M

What is Bionano Genomics TTM CFI year-on-year change?

Over the past year, BNGO TTM cash flow from investing activities has changed by -$8.69 M (-35.97%)